ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,347.40
0.45%
S&P ASX All Technology
3,799.90
0.91%
Brent Oil
79.645
-0.71%
US Dollar vs AUD
1.61147
-0.17%
Bitcoin
107,447.84
4.20%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Ab Science Sa (0Q77) Share Price

Ab Science Sa

Ab Science Sa (0Q77)

LSE
3.835
0.00
( 0.00% )
Updated: 11:00:00
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.835
Bid
3.74
Offer
3.93
Volume
3,438
0.00 Day's Range 0.00
3.835 52 Week Range 3.835
Market Cap
178.719M
Previous Close
3.835
Open
-
Last Trade
17
@
1.82
(O)
Last Trade Time
23:10:32
Financial Volume
-
VWAP
-
Average Volume (3m)
4,835
Shares Outstanding
46,602,000
Dividend Yield
-
PE Ratio
-7.08
Earnings Per Share (EPS)
-0.26
Revenue
970k
Net Profit
-11.99M

About Ab Science Sa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ab-science.com
Headquarters
Paris, Paris, Fra
Founded
-
Ab Science Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0Q77. The last closing price for Ab Science was 3.84 €. Over the last year, Ab Science shares have traded in a share price range of 3.835 € to 3.835 €.

Ab Science currently has 46,602,000 shares in issue. The market capitalisation of Ab Science is 178.72 € million. Ab Science has a price to earnings ratio (PE ratio) of -7.08.

Ask ADVFN Intelligence (AI)

0Q77 Latest News

More News

AB Science provides a summary of the webcast held on December 16, 2024

AB Science provides a summary of the webcast held on December 16, 2024 PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON AB8939, A NOVEL MICROTUBULE DESTABILIZER ESCAPING MULTIDRUG RESISTANCE AND...

18 December 2024
UK Regulatory

AB Science fournit un résumé de la conférence virtuelle qui s’est tenue le 16 décembre 2024

AB Science fournit un résumé de la conférence virtuelle qui s’est tenue le 16 décembre 2024 COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR LA MOLECULE AB8939, UN NOUVEAU DÉSTABILISATEUR DE...

18 December 2024
UK Regulatory

AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30

AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30 COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 16 DECEMBRE 2024, DE 17H30 A 18H30...

12 December 2024
UK Regulatory

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET...

12 December 2024
UK Regulatory

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

29 October 2024
UK Regulatory

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

29 October 2024
UK Regulatory

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL...

18 October 2024
UK Regulatory

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE...

18 October 2024
UK Regulatory

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science          COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE...

10 October 2024
UK Regulatory

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities          PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS...

10 October 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.8353.8353.83556033.835DE
4003.8353.8353.835141563.835DE
12003.8353.8353.83548353.835DE
26003.8353.8353.83524333.835DE
52003.8353.8353.83525563.835DE
156003.8353.8353.83548403.835DE
260003.8353.8353.83547383.835DE

0Q77 - Frequently Asked Questions (FAQ)

What is the current Ab Science share price?
The current share price of Ab Science is 3.835 €
How many Ab Science shares are in issue?
Ab Science has 46,602,000 shares in issue
What is the market cap of Ab Science?
The market capitalisation of Ab Science is EUR 178.72M
What is the 1 year trading range for Ab Science share price?
Ab Science has traded in the range of 3.835 € to 3.835 € during the past year
What is the PE ratio of Ab Science?
The price to earnings ratio of Ab Science is -7.08
What is the cash to sales ratio of Ab Science?
The cash to sales ratio of Ab Science is 87.5
What is the reporting currency for Ab Science?
Ab Science reports financial results in EUR
What is the latest annual turnover for Ab Science?
The latest annual turnover of Ab Science is EUR 970k
What is the latest annual profit for Ab Science?
The latest annual profit of Ab Science is EUR -11.99M
What is the registered address of Ab Science?
The registered address for Ab Science is 3 AVENUE GEORGE V, PARIS, PARIS, 75008
What is the Ab Science website address?
The website address for Ab Science is www.ab-science.com
Which industry sector does Ab Science operate in?
Ab Science operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BLUBlue Star Capital Plc
12.25p
(48.48%)
1.07M
NTQEnteq Technologies Plc
1.45p
(45.00%)
18.81M
TIRTiger Royalties And Investments Plc
0.17p
(36.00%)
130.37M
NFXNuformix Plc
0.07p
(33.33%)
32.19M
TRLSTrellus Health Plc
3.10p
(29.17%)
10.49M
PODPPod Point Group Holdings Plc
10.50p
(-37.46%)
5.64M
PALMPanther Metals Plc
52.50p
(-36.36%)
208.71k
NOGNostrum Oil & Gas Plc
2.51p
(-23.82%)
117.55k
PRDPredator Oil & Gas Holdings Plc
5.75p
(-22.30%)
5.05M
ADMEAdm Energy Plc
0.175p
(-22.22%)
991.32k
NTVONativo Resources Plc
0.002p
(5.26%)
721.2M
TRPTower Resources Plc
0.0315p
(1.61%)
404.76M
PREMPremier African Minerals Limited
0.027p
(-3.57%)
395.25M
TYMTertiary Minerals Plc
0.075p
(7.14%)
234.74M
ORCPOracle Power Plc
0.0155p
(-8.82%)
232.63M

Discussion

View Full Feed
Think1st Think1st 1 minute ago
So its NOT DARK POOL, NOT WHEN STOCK FALLS ITS REALLY BUYING AN INSIDER WAS SELLING among others and you kept and keep pumping differently
Shame on you
Imo
LWLG
pennystock_es pennystock_es 1 minute ago
What does this mean? Are you still a construction company? We need to rebuild the US!!
THBD
StayHumble StayHumble 2 minutes ago
💹wow 80-$99 INCOMING! 💹 UCLA💹Xerox|Mercedes|Santander|AbbeyRoadInst|Chatsworth|Ernst&Young|Omnisport|PinsentMasons
https://www.dbmmgroup.com/wp-content/uploads/2024/03/DBMM_Creds_Deck_2024_2.pdf
https://investorshub.advfn.com/uimage/uploads/2024/12/23/betnvDBMM
DBMM
TenKay TenKay 3 minutes ago
“or vice versa“

You took the phrase “order-marking” and turned it into “Misclassification of Transactions: Marking short sales incorrectly as long sales” which is not what the SEC actually said and is only one type instance of incorrect order marking. There can be six different ways
HMBL
LandPro LandPro 5 minutes ago
An "OTC stock pumper" refers to an individual or group who deliberately promotes and artificially inflates the price of a stock that trades on the over-the-counter (OTC) market by spreading false or misleading information, often with the intention of selling their own shares at a higher price once t
RDAR
navycmdr navycmdr 5 minutes ago
WSJ - Which Trump Trades Worked—and Which Very Much Didn’t

What has worked:

Fannie and Freddie: Best of all in percentage terms has been the bet on the new administration

privatizing the mortgage-finance giants, which holders of the preferred shares th
FNMA
ANTI-BAGHOLDER ANTI-BAGHOLDER 5 minutes ago

Version 1.5 out:


MONI
Gmenfan Gmenfan 6 minutes ago
Wow ... This is quite a precedent to try to set. Looks like a President could preemptively pardon people far into the future. We'll see if this stands!
sharkey1 sharkey1 6 minutes ago
First search, page 2 I see Elite. Adderall
https://mms.mckesson.com/catalog?node=403098+5616279&pageOffset=1

But you have to log in to get details
ELTP
PrimeTimeRise PrimeTimeRise 7 minutes ago
"Focus #4 – Completing a large sale of our Water Less Garden® into the Middle East by end of Q2-2025"
Bullish
SGTM
PrimeTimeRise PrimeTimeRise 7 minutes ago
"Focus #4 – Completing a large sale of our Water Less Garden® into the Middle East by end of Q2-2025"
Bullish
SGTM
Gmenfan Gmenfan 7 minutes ago
Wow ... This is quite a precedent to try to set. Looks like a President could preemptively pardon people far into the future. We'll see if this stands!

Biden issues preemptive pardons for Milley, Fauci and Jan. 6 committee members

Stephanie Scarbrough/AP
Washin
Gene Oh Gene Oh 7 minutes ago
Happy Inauguration Day to my 'Merican Friends!!!

Our day is coming soon...but not soon enough...
MVNT
PrimeTimeRise PrimeTimeRise 9 minutes ago
Check out the company YouTube page for all their latest videos!
https://www.youtube.com/@sgtmthesustainablegreentea5261
SGTM
KS46268 KS46268 9 minutes ago
Has CSE shown Active the whole time halted or is this newly updated?
https://thecse.com/listings/two-hands-corporation/#quote CSE 8:30 am 1/20 Status Active
TWOH
PennyStockTrader2 PennyStockTrader2 11 minutes ago
CGLD has been a long term hold and trade. After taking nice profits in the spike of gold mining news, they announced the Solar Concentrator venture, and might be looking at other ventures as well. In the meantime I have captured a third of the float. IF they can come through with something that can
CGLD
TheDane TheDane 11 minutes ago
Thanks for posting this. These people are despicable. Hope they get what they deserve.

But they’ve shut down then what are the odds of a short squeeze? Wouldn’t they already have covered?
SMCI
georgie18 georgie18 12 minutes ago
BITCOIN...$106,990...🥳...As expected BITCOIN set a new high at $109,340...Still looking for the $110,000 Breakout...

georgie18

Member Level
Re: georgie18 post# 388715

Friday, January 17, 2025 2:47:45 PM

Post#
388756
LandPro LandPro 12 minutes ago
An "OTC stock pumper" refers to an individual or group who deliberately promotes and artificially inflates the price of a stock that trades on the over-the-counter (OTC) market by spreading false or misleading information, often with the intention of selling their own shares at a higher price once t
GRST
georgie18 georgie18 12 minutes ago
BITCOIN...$106,990...🥳...As expected BITCOIN set a new high at $109,340...Still looking for the $110,000 Breakout...

georgie18

Member Level
Re: georgie18 post# 388715

Friday, January 17, 2025 2:47:45 PM

Post#
388756
Smartypants2 Smartypants2 12 minutes ago
NoScared, In XERI's December 16th press release, they committed to being more transparent. ("The Company is now actively committed to ensuring shareholders and the investment community are well-informed about its progress and strategic developments." SEE LINK BELOW)
At times, they apparent
XERI
nickypicky nickypicky 12 minutes ago
This should be much higher soon.
MARA
navycmdr navycmdr 13 minutes ago
Fannie / Freddie are on the Launch Pad of FREEDOM !

https://investorshub.advfn.com/uimage/uploads/2025/1/18/vcomvMLK.JPG

" A REVOLUTION of $COMMON SENSE "

https://investorshub.advfn.com/uimage/uploads/2025/1/20/kwcxfDJT.JPG
COMMON
PennyStockTrader2 PennyStockTrader2 14 minutes ago
This one is a real sleeper. See their web page https://nascentpharmaholdings.com/ where you can see they have huge plans with their patents to collect money from large companies using them across multiple industries. I would expect something in the next couple months and have positioned myself appro
CANB
PrimeTimeRise PrimeTimeRise 15 minutes ago
NOGOBEAVER needs to get a life and stop attacking American entrepreneurial companies. It’s disheartening to see someone with seemingly good intentions spend their time bullying others instead of recognizing the incredible resilience and innovation within our business community.

Many c
SGTM

Your Recent History

LSE
0Q77
Ab Science
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads